GlassScriptPhysician profile
Kevin S Chen
NPI 1396760781
$1,019.95
in general payments reported to CMS, 2019-2025
18 companies · $74.75 in 2025
The $74.75 reported for 2025 was more than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $88.96 · 2020: $106 · 2021: $20.08 · 2022: $252 · 2023: $410 · 2024: $67.95 · 2025: $74.75.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $553.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $552.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $341.03 | 2022-2024 | Stelara |
| Takeda Pharmaceuticals U.S.A., INC. | $129.91 | 2021-2023 | Entyvio |
| Merck Sharp & Dohme LLC | $97.71 | 2020-2025 | Bridion |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $48.29 | 2020 | |
| Becton, Dickinson and Company | $46.62 | 2025 | |
| Acacia Pharma INC | $43.06 | 2022 | |
| Intercept Pharmaceuticals, INC. | $36.09 | 2022-2023 | Ocaliva |
| Braintree Laboratories, INC. | $33.10 | 2022-2023 | Sutab |
| Pacira Pharmaceuticals Incorporated | $32.48 | 2019 | |
| Ardelyx, INC. | $31.89 | 2023-2024 | Ibsrela |
| Haemonetics Corporation | $28.87 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $28.02 | 2023 | Dupixent |
| Cumberland Pharmaceuticals, INC. | $23.75 | 2019 | |
| Medtronic, INC. | $23.52 | 2024 | Bis |
| Abbvie INC. | $22.95 | 2023 | Viberzi, Linzess |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $19.93 | 2022 | |
| Ge Healthcare | $19.84 | 2019 | |
| Ucb, INC. | $12.89 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.